JIANMIN GROUP: Clinical trial for BiYuan TongQiao granules drug approved

Zhitong
2025.08.14 10:26

On the evening of August 14th, JIANMIN GROUP announced that the company recently received the "Drug Clinical Trial Approval Notification" issued by the National Medical Products Administration for the Nasal Congestion Relief Granules, which is indicated for acute sinusitis

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer